CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

L. Vroling, J.S.W. Lind, R.R. de Haas, H.M.W. Verheul, V.W.M. van Hinsbergh, H.J. Broxterman, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

43 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)268-275
JournalBritish Journal of Cancer
Volume102
Issue number2
DOIs
Publication statusPublished - 2010

Cite this

@article{50faba04f6e64a6893331f701484c6cc,
title = "CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients",
author = "L. Vroling and J.S.W. Lind and {de Haas}, R.R. and H.M.W. Verheul and {van Hinsbergh}, V.W.M. and H.J. Broxterman and E.F. Smit",
year = "2010",
doi = "10.1038/sj.bjc.6605477",
language = "Undefined/Unknown",
volume = "102",
pages = "268--275",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients. / Vroling, L.; Lind, J.S.W.; de Haas, R.R.; Verheul, H.M.W.; van Hinsbergh, V.W.M.; Broxterman, H.J.; Smit, E.F.

In: British Journal of Cancer, Vol. 102, No. 2, 2010, p. 268-275.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

AU - Vroling, L.

AU - Lind, J.S.W.

AU - de Haas, R.R.

AU - Verheul, H.M.W.

AU - van Hinsbergh, V.W.M.

AU - Broxterman, H.J.

AU - Smit, E.F.

PY - 2010

Y1 - 2010

U2 - 10.1038/sj.bjc.6605477

DO - 10.1038/sj.bjc.6605477

M3 - Article

VL - 102

SP - 268

EP - 275

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -